Adverse reactions of tumor immunotherapy drugs—PD-1/PD-L1 inhibitors
CHEN Shuang, ZHENG Shufen, ZHANG Shuyao, ZHONG Shilong
Chinese Journal of Pharmacovigilance . 2022, (10): 1107 -1112 .  DOI: 10.19803/j.1672-8629.20210124